1. Home
  2. TVTX vs AUGO Comparison

TVTX vs AUGO Comparison

Compare TVTX & AUGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$56.17

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Logo Aura Minerals Inc.

AUGO

Aura Minerals Inc.

HOLD

Current Price

$54.49

Market Cap

4.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
AUGO
Founded
N/A
1946
Country
United States
United States
Employees
N/A
1462
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.8B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
TVTX
AUGO
Price
$56.17
$54.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
3
Target Price
$40.62
$67.60
AVG Volume (30 Days)
1.8M
1.0M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
1.97%
EPS Growth
92.89
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$44.76
$91.05
Revenue Next Year
$35.51
$17.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.03
$23.55
52 Week High
$60.10
$110.32

Technical Indicators

Market Signals
Indicator
TVTX
AUGO
Relative Strength Index (RSI) 55.14 42.02
Support Level $54.87 $50.75
Resistance Level $59.89 $54.30
Average True Range (ATR) 2.37 3.74
MACD -0.66 -0.63
Stochastic Oscillator 46.64 28.78

Price Performance

Historical Comparison
TVTX
AUGO

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

About AUGO Aura Minerals Inc.

Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.

Share on Social Networks: